Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 130

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1A
Chunk 130
---
 to ATM program 
     3,328  
     - 
  
    Exercise of warrants 
     176  
     - 
  
    Repayment of notes payable 
     (776) 
     - 
  
    Proceeds from issuance of warrants 
     113  
     - 
  
    Proceeds from issuance of convertible promissory note payable, carried at cost 
     -  
     2,286 
  
    Net cash flows from financing activities 
     6,067  
     10,929 
  
    Net change in cash and cash equivalents before effect of exchange rate changes 
     (3,658) 
     3,929 
  
    Effect of exchange rate changes on cash and cash equivalents 
     (16) 
     299 
  
    Net change in cash 
     (3,674) 
     4,228 
  
    Cash and cash equivalents at beginning of period 
     4,228  
     - 
  
    Cash and cash equivalents at end of period 
    $554  
    $4,228 

    Non-cash investing and financing activities 

    Right of Use Asset obtained in exchange for Operating Lease Liabilities 
    $352  
    $- 
  
    Correction of immaterial error related to franchise tax expense 
    $144  
    $- 
  
    Issuance of Common Stock upon exercise of conversion option 
    $92  
    $- 
  
    Issuance of Common Stock in exchange for debt extension 
    $489  
    $- 
  
    Conversion of deferred commission payable to convertible promissory note 
    $5,378  
    $- 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to Cizzle Biotechnology Holding PLC upon exercise of option 
    $-  
    $151 
  
    Issuance of Conduit Pharmaceuticals Inc. common stock to Vela Technologies PLC upon exercise of option 
    $-  
    $544 
  
    Exchange of Conduit Pharmaceuticals Limited convertible notes for shares of Conduit Pharmaceuticals Inc. common stock in connection with the Merger 
    $-  
    $3,685 
  
    Deferred Underwriting Costs 
    $-  
    $5,738 
  
    Prepaid expense of directors and officers insurance paid out of PIPE financings proceeds in connection with the Merger 
    $-